Isnardo Tremor
Family Medicine · Huntsville, TXNPI 1538167390
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $524 and has fallen 96.0% since, to $21 in 2025.
Across 75 payments — averaging $14.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$213
- AstraZeneca$114
- Johnson & Johnson$94
- Sanofi-aventis U.S. LLC$73
- Dexcom, Inc.$63
- Amgen$57
- plus $494 from 18 others
What the payments were for
- Food & beverage$1,109100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 18 | $213 |
| AstraZeneca | 8 | $114 |
| Johnson & Johnson | 7 | $94 |
| Sanofi-aventis U.S. LLC | 5 | $73 |
| Dexcom, Inc. | 3 | $63 |
| Amgen | 4 | $57 |
| Astellas Pharma US Inc | 3 | $51 |
| Novartis | 3 | $45 |
| Boehringer Ingelheim | 3 | $44 |
| Scilex Pharmaceuticals Inc. | 1 | $42 |
| AbbVie(2 entities) | 3 | $41 |
| Sunovion Pharmaceuticals Inc. | 3 | $40 |
| Vertiflex, Inc. | 1 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| GSK | 2 | $28 |
| Amarin Pharma, Inc. | 1 | $24 |
| Mylan Specialty L.p. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Emergent Biosolutions Inc. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$1,109 in reported general payments places this provider in the 60th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 15 | $164 |
| Amlodipine Besylate | 13 | $46 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Huntsville
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.